1. Home
  2. PAHC vs DLX Comparison

PAHC vs DLX Comparison

Compare PAHC & DLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • DLX
  • Stock Information
  • Founded
  • PAHC 1946
  • DLX 1915
  • Country
  • PAHC United States
  • DLX United States
  • Employees
  • PAHC N/A
  • DLX N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • DLX Advertising
  • Sector
  • PAHC Health Care
  • DLX Consumer Discretionary
  • Exchange
  • PAHC Nasdaq
  • DLX Nasdaq
  • Market Cap
  • PAHC 871.9M
  • DLX 709.6M
  • IPO Year
  • PAHC 2014
  • DLX N/A
  • Fundamental
  • Price
  • PAHC $19.34
  • DLX $14.39
  • Analyst Decision
  • PAHC Sell
  • DLX Strong Buy
  • Analyst Count
  • PAHC 4
  • DLX 2
  • Target Price
  • PAHC $21.00
  • DLX $31.00
  • AVG Volume (30 Days)
  • PAHC 231.1K
  • DLX 311.0K
  • Earning Date
  • PAHC 05-07-2025
  • DLX 04-30-2025
  • Dividend Yield
  • PAHC 2.38%
  • DLX 7.82%
  • EPS Growth
  • PAHC 30.53
  • DLX 99.86
  • EPS
  • PAHC 0.48
  • DLX 1.18
  • Revenue
  • PAHC $1,106,080,000.00
  • DLX $2,121,761,000.00
  • Revenue This Year
  • PAHC $28.43
  • DLX $0.86
  • Revenue Next Year
  • PAHC $10.10
  • DLX $1.12
  • P/E Ratio
  • PAHC $42.38
  • DLX $13.78
  • Revenue Growth
  • PAHC 12.63
  • DLX N/A
  • 52 Week Low
  • PAHC $12.30
  • DLX $15.09
  • 52 Week High
  • PAHC $26.55
  • DLX $24.87
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 32.17
  • DLX 31.14
  • Support Level
  • PAHC $20.80
  • DLX $15.50
  • Resistance Level
  • PAHC $22.41
  • DLX $16.31
  • Average True Range (ATR)
  • PAHC 0.72
  • DLX 0.46
  • MACD
  • PAHC -0.17
  • DLX 0.04
  • Stochastic Oscillator
  • PAHC 5.19
  • DLX 6.76

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About DLX Deluxe Corporation

Deluxe Corporation is principally a payments and data company. Its reportable segments are; Merchant Services, B2B Payments, Data Solutions, and Print. Maximum revenue is derived from its Print segment which provides printed personal and business checks, business essentials, as well as branded promotional, print, apparel, and digital storefront solutions. The Merchant Services segment provides electronic credit and debit card authorization, payment systems, and processing services. The B2B segment offers treasury management solutions, integrated accounts payable disbursements, and fraud and security services, and the Data Solutions segment offers data, analytics, and marketing services as well as financial institution profitability reporting and business incorporation services.

Share on Social Networks: